Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för John C Martin. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att John C Martin har rapporterat innehav eller affärer i följande företag:
| Värdepapper | Titel | Senaste rapporterade innehav |
|---|---|---|
| US:SRPT / Sarepta Therapeutics, Inc. | Director | 5 518 |
| US:KRON / Kronos Bio, Inc. | Director | 0 |
| US:GILD / Gilead Sciences, Inc. | Director | 2 887 225 |
| Director | 0 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av John C Martin. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av John C Martin som avslöjats för Securities Exchange Commission (SEC).
| Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-03-05 |
|
4 | SRPT |
Sarepta Therapeutics, Inc.
Stock Option (right to buy) |
A - Award | 5 518 | 5 518 | |||||
| 2021-03-05 |
|
4 | SRPT |
Sarepta Therapeutics, Inc.
Common Stock |
A - Award | 2 726 | 7 913 | 52,55 | ||||
| 2020-10-16 |
|
4 | KRON |
Kronos Bio, Inc.
Series Seed Preferred Stock |
C - Conversion | −866 667 | 0 | −100,00 | ||||
| 2020-10-16 |
|
4 | KRON |
Kronos Bio, Inc.
Convertible Promissory Note |
C - Conversion | 0 | ||||||
| 2020-10-16 |
|
4 | KRON |
Kronos Bio, Inc.
Series A Preferred Stock |
C - Conversion | −717 509 | 0 | −100,00 | ||||
| 2020-10-16 |
|
4 | KRON |
Kronos Bio, Inc.
Common Stock |
P - Purchase | 75 800 | 1 952 364 | 4,04 | 19,00 | 1 440 200 | 37 094 916 | |
| 2020-10-16 |
|
4 | KRON |
Kronos Bio, Inc.
Common Stock |
C - Conversion | 205 260 | 1 876 564 | 12,28 | 16,15 | 3 314 949 | 30 306 509 | |
| 2020-10-16 |
|
4 | KRON |
Kronos Bio, Inc.
Common Stock |
C - Conversion | 756 971 | 1 671 304 | 82,79 | ||||
| 2020-10-16 |
|
4 | KRON |
Kronos Bio, Inc.
Common Stock |
C - Conversion | 914 333 | 914 333 | |||||
| 2020-02-28 |
|
4 | SRPT |
Sarepta Therapeutics, Inc.
Stock option (right to buy) |
A - Award | 3 685 | 3 685 | |||||
| 2020-02-28 |
|
4 | SRPT |
Sarepta Therapeutics, Inc.
Stock option (right to buy) |
A - Award | 5 528 | 5 528 | |||||
| 2020-02-28 |
|
4 | SRPT |
Sarepta Therapeutics, Inc.
Common Stock |
A - Award | 2 075 | 5 187 | 66,68 | ||||
| 2020-02-28 |
|
4 | SRPT |
Sarepta Therapeutics, Inc.
Common Stock |
A - Award | 3 112 | 3 112 | |||||
| 2019-02-08 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
F - Taxes | −13 787 | 2 887 225 | −0,48 | 68,75 | −947 856 | 198 496 719 | |
| 2019-02-08 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
A - Award | 15 505 | 2 901 012 | 0,54 | ||||
| 2019-02-08 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
A - Award | 7 745 | 2 885 507 | 0,27 | ||||
| 2018-12-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −50 000 | 0 | −100,00 | |||
| 2018-12-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −200 | 2 877 762 | −0,01 | 72,66 | −14 533 | 209 112 576 | |
| 2018-12-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −13 958 | 2 877 962 | −0,48 | 71,95 | −1 004 275 | 207 068 790 | |
| 2018-12-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −35 842 | 2 891 920 | −1,22 | 70,90 | −2 541 370 | 205 051 009 | |
| 2018-12-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | X | 50 000 | 2 927 762 | 1,74 | 23,60 | 1 180 000 | 69 095 183 |
| 2018-12-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
G - Gift | −140 000 | 2 877 762 | −4,64 | ||||
| 2018-11-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −50 000 | 50 000 | −50,00 | |||
| 2018-11-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −13 579 | 3 017 762 | −0,45 | 70,15 | −952 632 | 211 710 490 | |
| 2018-11-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −28 421 | 3 031 341 | −0,93 | 69,53 | −1 976 135 | 210 771 565 | |
| 2018-11-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −8 000 | 3 059 762 | −0,26 | 68,61 | −548 850 | 209 918 950 | |
| 2018-11-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | X | 50 000 | 3 067 762 | 1,66 | 23,60 | 1 180 000 | 72 399 183 |
| 2018-10-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −50 000 | 100 000 | −33,33 | |||
| 2018-10-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −16 670 | 3 017 762 | −0,55 | 78,34 | −1 305 853 | 236 397 895 | |
| 2018-10-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −33 330 | 3 034 432 | −1,09 | 77,90 | −2 596 357 | 236 377 701 | |
| 2018-10-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | X | 50 000 | 3 067 762 | 1,66 | 23,60 | 1 180 000 | 72 399 183 |
| 2018-09-06 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −50 000 | 150 000 | −25,00 | |||
| 2018-09-06 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −2 624 | 3 017 762 | −0,09 | 75,00 | −196 790 | 226 320 683 | |
| 2018-09-06 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −47 376 | 3 020 386 | −1,54 | 74,11 | −3 511 244 | 223 854 096 | |
| 2018-09-06 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | X | 50 000 | 3 067 762 | 1,66 | 23,60 | 1 180 000 | 72 399 183 |
| 2018-08-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −50 000 | 200 000 | −20,00 | |||
| 2018-08-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −50 000 | 3 017 762 | −1,63 | 77,85 | −3 892 650 | 234 941 825 | |
| 2018-08-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | X | 50 000 | 3 067 762 | 1,66 | 23,60 | 1 180 000 | 72 399 183 |
| 2018-07-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −50 000 | 250 000 | −16,67 | |||
| 2018-07-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −300 | 3 017 762 | −0,01 | 71,36 | −21 408 | 215 347 496 | |
| 2018-07-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −49 700 | 3 018 062 | −1,62 | 70,80 | −3 518 874 | 213 685 731 | |
| 2018-07-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | X | 50 000 | 3 067 762 | 1,66 | 23,60 | 1 180 000 | 72 399 183 |
| 2018-06-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −50 000 | 300 000 | −14,29 | |||
| 2018-06-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −50 000 | 3 017 762 | −1,63 | 68,13 | −3 406 495 | 205 599 823 | |
| 2018-06-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | X | 50 000 | 3 067 762 | 1,66 | 23,60 | 1 180 000 | 72 399 183 |
| 2018-05-11 |
|
4 | GILD |
GILEAD SCIENCES INC
Restricted Stock Unit |
A - Award | 2 283 | 2 593 | 736,45 | ||||
| 2018-05-11 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy) |
A - Award | 9 496 | 9 496 | |||||
| 2018-05-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −50 000 | 350 000 | −12,50 | |||
| 2018-05-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −50 000 | 3 017 762 | −1,63 | 72,19 | −3 609 660 | 217 861 896 | |
| 2018-05-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | X | 50 000 | 3 067 762 | 1,66 | 23,60 | 1 180 000 | 72 399 183 |
| 2018-04-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −50 000 | 400 000 | −11,11 | |||
| 2018-04-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −700 | 3 017 762 | −0,02 | 74,98 | −52 484 | 226 263 043 | |
| 2018-04-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −9 962 | 3 018 462 | −0,33 | 74,33 | −740 466 | 224 359 564 | |
| 2018-04-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −13 080 | 3 028 424 | −0,43 | 73,39 | −959 890 | 222 244 227 | |
| 2018-04-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −26 258 | 3 041 504 | −0,86 | 72,51 | −1 903 965 | 220 539 151 | |
| 2018-04-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | X | 50 000 | 3 067 762 | 1,66 | 23,60 | 1 180 000 | 72 399 183 |
| 2018-03-13 |
|
4 | GILD |
GILEAD SCIENCES INC
Restricted Stock Unit |
A - Award | 310 | 310 | |||||
| 2018-03-13 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy) |
A - Award | 1 309 | 1 309 | |||||
| 2018-03-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −50 000 | 450 000 | −10,00 | |||
| 2018-03-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −6 523 | 3 017 762 | −0,22 | 79,49 | −518 522 | 239 885 824 | |
| 2018-03-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −26 575 | 3 024 285 | −0,87 | 78,95 | −2 098 200 | 238 779 095 | |
| 2018-03-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −16 902 | 3 050 860 | −0,55 | 77,84 | −1 315 653 | 237 479 247 | |
| 2018-03-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | X | 50 000 | 3 067 762 | 1,66 | 23,60 | 1 180 000 | 72 399 183 |
| 2018-02-23 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
F - Taxes | −19 354 | 3 017 762 | −0,64 | 80,69 | −1 561 674 | 243 503 216 | |
| 2018-02-23 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
A - Award | 18 630 | 3 037 116 | 0,62 | ||||
| 2018-02-23 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
A - Award | 21 380 | 3 018 486 | 0,71 | ||||
| 2018-02-23 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
A - Award | 340 | 2 997 106 | 0,01 | 62,35 | 21 198 | 186 862 066 | |
| 2018-02-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −50 000 | 500 000 | −9,09 | |||
| 2018-02-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −30 723 | 2 996 766 | −1,01 | 83,69 | −2 571 125 | 250 791 255 | |
| 2018-02-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −19 277 | 3 027 489 | −0,63 | 83,35 | −1 606 699 | 252 335 153 | |
| 2018-02-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | X | 50 000 | 3 046 766 | 1,67 | 23,60 | 1 180 000 | 71 903 678 |
| 2018-01-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −50 000 | 550 000 | −8,33 | |||
| 2018-01-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −18 954 | 2 996 766 | −0,63 | 73,95 | −1 401 614 | 221 605 452 | |
| 2018-01-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −26 941 | 3 015 720 | −0,89 | 73,60 | −1 982 987 | 221 971 467 | |
| 2018-01-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −4 105 | 3 042 661 | −0,13 | 72,26 | −296 634 | 219 867 856 | |
| 2018-01-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | X | 50 000 | 3 046 766 | 1,67 | 23,60 | 1 180 000 | 71 903 678 |
| 2017-12-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −73 333 | 0 | −100,00 | |||
| 2017-12-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −12 500 | 2 996 766 | −0,42 | 74,35 | −929 409 | 222 817 643 | |
| 2017-12-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −101 | 3 009 266 | 0,00 | 75,57 | −7 633 | 227 410 533 | |
| 2017-12-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −60 732 | 3 009 367 | −1,98 | 75,11 | −4 561 344 | 226 021 819 | |
| 2017-12-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | X | 73 333 | 3 070 099 | 2,45 | 21,58 | 1 582 159 | 66 237 386 |
| 2017-11-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −73 333 | 73 333 | −50,00 | |||
| 2017-11-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −7 477 | 2 996 766 | −0,25 | 75,60 | −565 295 | 226 568 995 | |
| 2017-11-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −65 856 | 3 004 243 | −2,15 | 75,08 | −4 944 403 | 225 555 560 | |
| 2017-11-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | X | 73 333 | 3 070 099 | 2,45 | 21,58 | 1 582 159 | 66 237 386 |
| 2017-10-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −73 333 | 146 666 | −33,33 | |||
| 2017-10-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −68 133 | 2 996 766 | −2,22 | 82,62 | −5 628 855 | 247 579 921 | |
| 2017-10-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −5 200 | 3 064 899 | −0,17 | 81,82 | −425 464 | 250 770 036 | |
| 2017-10-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | X | 73 333 | 3 070 099 | 2,45 | 21,58 | 1 582 159 | 66 237 386 |
| 2017-09-06 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −73 333 | 219 999 | −25,00 | |||
| 2017-09-06 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −14 995 | 2 996 766 | −0,50 | 83,43 | −1 251 094 | 250 032 474 | |
| 2017-09-06 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −58 338 | 3 011 761 | −1,90 | 83,03 | −4 843 897 | 250 071 335 | |
| 2017-09-06 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | X | 73 333 | 3 070 099 | 2,45 | 21,58 | 1 582 159 | 66 237 386 |
| 2017-09-06 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
G - Gift | −129 870 | 2 996 766 | −4,15 | ||||
| 2017-08-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −73 333 | 293 332 | −20,00 | |||
| 2017-08-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −73 333 | 3 126 636 | −2,29 | 75,86 | −5 562 777 | 237 175 351 | |
| 2017-08-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | X | 73 333 | 3 199 969 | 2,35 | 21,58 | 1 582 159 | 69 039 331 |
| 2017-07-06 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −73 333 | 366 665 | −16,67 | |||
| 2017-07-06 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −73 333 | 3 126 636 | −2,29 | 71,00 | −5 206 892 | 222 001 787 | |
| 2017-07-06 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | X | 73 333 | 3 199 969 | 2,35 | 21,58 | 1 582 159 | 69 039 331 |
| 2017-06-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −73 333 | 293 332 | −20,00 | |||
| 2017-06-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −73 333 | 3 199 969 | −2,24 | 65,24 | −4 784 531 | 208 778 457 | |
| 2017-06-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | X | 73 333 | 3 273 302 | 2,29 | 21,58 | 1 582 159 | 70 621 491 |
| 2017-05-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −73 333 | 513 331 | −12,50 | |||
| 2017-05-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −73 333 | 3 126 636 | −2,29 | 68,31 | −5 009 429 | 213 582 694 | |
| 2017-05-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | X | 73 333 | 3 199 969 | 2,35 | 21,58 | 1 582 159 | 69 039 331 |
| 2017-04-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −73 333 | 586 664 | −11,11 | |||
| 2017-04-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −10 500 | 3 126 636 | −0,33 | 67,85 | −712 385 | 212 130 371 | |
| 2017-04-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −62 833 | 3 137 136 | −1,96 | 67,07 | −4 213 901 | 210 392 340 | |
| 2017-04-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | X | 73 333 | 3 199 969 | 2,35 | 21,58 | 1 582 159 | 69 039 331 |
| 2017-03-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −73 333 | 659 997 | −10,00 | |||
| 2017-03-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −73 333 | 3 126 636 | −2,29 | 70,38 | −5 161 206 | 220 053 892 | |
| 2017-03-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | X | 73 333 | 3 199 969 | 2,35 | 21,58 | 1 582 159 | 69 039 331 |
| 2017-02-21 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy) |
A - Award | 123 210 | 123 210 | |||||
| 2017-02-21 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
F - Taxes | −25 271 | 3 126 636 | −0,80 | 70,31 | −1 776 804 | 219 833 777 | |
| 2017-02-21 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
A - Award | 8 572 | 3 151 907 | 0,27 | ||||
| 2017-02-21 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
A - Award | 11 924 | 3 143 335 | 0,38 | ||||
| 2017-02-21 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
A - Award | 315 | 3 131 411 | 0,01 | 59,33 | 18 689 | 185 786 615 | |
| 2017-02-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −73 333 | 733 330 | −9,09 | |||
| 2017-02-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −73 333 | 3 131 096 | −2,29 | 72,57 | −5 322 069 | 227 236 161 | |
| 2017-02-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | X | 73 333 | 3 204 429 | 2,34 | 21,58 | 1 582 159 | 69 135 556 |
| 2017-01-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −73 337 | 806 663 | −8,33 | |||
| 2017-01-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −50 760 | 3 131 096 | −1,60 | 73,84 | −3 748 017 | 231 193 866 | |
| 2017-01-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −22 577 | 3 181 856 | −0,70 | 73,04 | −1 648 954 | 232 392 898 | |
| 2017-01-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | X | 73 337 | 3 204 433 | 2,34 | 21,58 | 1 582 246 | 69 135 642 |
| 2016-12-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −100 000 | 0 | −100,00 | |||
| 2016-12-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −100 000 | 3 131 096 | −3,09 | 73,33 | −7 332 870 | 229 599 199 | |
| 2016-12-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | X | 100 000 | 3 231 096 | 3,19 | 16,40 | 1 639 500 | 52 973 819 |
| 2016-11-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −100 000 | 100 000 | −50,00 | |||
| 2016-11-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −6 400 | 3 131 096 | −0,20 | 74,15 | −474 591 | 232 185 798 | |
| 2016-11-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −93 600 | 3 137 496 | −2,90 | 73,73 | −6 901 456 | 231 338 561 | |
| 2016-11-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | X | 100 000 | 3 231 096 | 3,19 | 16,40 | 1 639 500 | 52 973 819 |
| 2016-10-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −100 000 | 200 000 | −33,33 | |||
| 2016-10-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −500 | 3 131 096 | −0,02 | 78,57 | −39 283 | 245 997 688 | |
| 2016-10-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −99 500 | 3 131 596 | −3,08 | 77,62 | −7 723 678 | 243 089 826 | |
| 2016-10-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | X | 100 000 | 3 231 096 | 3,19 | 16,40 | 1 639 500 | 52 973 819 |
| 2016-09-06 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | −100 000 | 300 000 | −25,00 | ||||
| 2016-09-06 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −4 400 | 3 131 096 | −0,14 | 78,19 | −344 047 | 244 828 537 | |
| 2016-09-06 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −95 600 | 3 135 496 | −2,96 | 77,45 | −7 404 316 | 242 847 301 | |
| 2016-09-06 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 100 000 | 3 231 096 | 3,19 | 16,40 | 1 639 500 | 52 973 819 | |
| 2016-09-06 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
G - Gift | −156 714 | 3 131 096 | −4,77 | ||||
| 2016-09-06 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
G - Gift | −731 917 | 3 287 810 | −18,21 | ||||
| 2016-09-06 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
J - Other | 731 917 | 731 917 | |||||
| 2016-08-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −100 000 | 400 000 | −20,00 | |||
| 2016-08-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −63 584 | 4 019 727 | −1,56 | 80,72 | −5 132 558 | 324 475 981 | |
| 2016-08-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −36 416 | 4 083 311 | −0,88 | 80,11 | −2 917 227 | 327 107 511 | |
| 2016-08-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | X | 100 000 | 4 119 727 | 2,49 | 16,40 | 1 639 500 | 67 542 924 |
| 2016-07-06 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −100 000 | 500 000 | −16,67 | |||
| 2016-07-06 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −30 718 | 4 019 727 | −0,76 | 85,03 | −2 612 093 | 341 815 878 | |
| 2016-07-06 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −64 582 | 4 050 445 | −1,57 | 84,68 | −5 468 629 | 342 980 746 | |
| 2016-07-06 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −4 700 | 4 115 027 | −0,11 | 83,36 | −391 801 | 343 036 469 | |
| 2016-07-06 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | X | 100 000 | 4 119 727 | 2,49 | 16,40 | 1 639 500 | 67 542 924 |
| 2016-06-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −100 000 | 600 000 | −14,29 | |||
| 2016-06-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −100 000 | 4 019 727 | −2,43 | 86,72 | −8 671 950 | 348 588 716 | |
| 2016-06-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | X | 100 000 | 4 119 727 | 2,49 | 16,40 | 1 639 500 | 67 542 924 |
| 2016-05-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −100 000 | 700 000 | −12,50 | |||
| 2016-05-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −48 982 | 4 019 727 | −1,20 | 88,26 | −4 322 960 | 354 765 428 | |
| 2016-05-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −51 018 | 4 068 709 | −1,24 | 87,40 | −4 458 733 | 355 586 044 | |
| 2016-05-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | X | 100 000 | 4 119 727 | 2,49 | 16,40 | 1 639 500 | 67 542 924 |
| 2016-04-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −100 000 | 800 000 | −11,11 | |||
| 2016-04-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −72 374 | 4 019 727 | −1,77 | 93,54 | −6 769 777 | 376 000 440 | |
| 2016-04-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −21 025 | 4 092 101 | −0,51 | 92,73 | −1 949 728 | 379 476 076 | |
| 2016-04-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −6 601 | 4 113 126 | −0,16 | 91,50 | −604 002 | 376 357 610 | |
| 2016-04-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | X | 100 000 | 4 119 727 | 2,49 | 16,40 | 1 639 500 | 67 542 924 |
| 2016-03-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −100 000 | 900 000 | −10,00 | |||
| 2016-03-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −73 826 | 4 019 727 | −1,80 | 88,86 | −6 560 112 | 357 189 323 | |
| 2016-03-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −26 174 | 4 093 553 | −0,64 | 87,79 | −2 297 742 | 359 361 556 | |
| 2016-03-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 100 000 | 4 119 727 | 2,49 | 16,40 | 1 639 500 | 67 542 924 | |
| 2016-02-18 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
F - Taxes | −122 901 | 4 019 727 | −2,97 | 91,19 | −11 207 342 | 366 558 905 | |
| 2016-02-18 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
A - Award | 154 328 | 4 142 628 | 3,87 | ||||
| 2016-02-18 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
A - Award | 39 986 | 3 988 300 | 1,01 | ||||
| 2016-02-18 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
A - Award | 248 | 3 948 314 | 0,01 | 76,02 | 18 854 | 300 166 624 | |
| 2016-02-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock option (right to buy) |
A - Award | 128 630 | 128 630 | |||||
| 2016-02-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock option (right to buy) |
M - Exercise | X | −100 000 | 1 000 000 | −9,09 | |||
| 2016-02-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −400 | 3 948 066 | −0,01 | 84,35 | −33 739 | 333 009 497 | |
| 2016-02-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −55 973 | 3 948 466 | −1,40 | 83,77 | −4 688 590 | 330 744 044 | |
| 2016-02-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −43 627 | 4 004 439 | −1,08 | 82,98 | −3 620 147 | 332 286 346 | |
| 2016-02-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 100 000 | 4 048 066 | 2,53 | 16,40 | 1 639 500 | 66 368 042 | |
| 2016-01-06 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock option (right to buy) |
M - Exercise | X | −100 000 | 1 100 000 | −8,33 | |||
| 2016-01-06 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −2 750 | 3 948 066 | −0,07 | 99,49 | −273 588 | 392 778 873 | |
| 2016-01-06 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −10 969 | 3 950 816 | −0,28 | 98,35 | −1 078 755 | 388 546 160 | |
| 2016-01-06 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −86 281 | 3 961 785 | −2,13 | 97,53 | −8 415 366 | 386 410 323 | |
| 2016-01-06 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 100 000 | 4 048 066 | 2,53 | 16,40 | 1 639 500 | 66 368 042 | |
| 2015-12-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock option (right to buy) |
M - Exercise | X | −150 000 | 0 | −100,00 | |||
| 2015-12-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −20 530 | 3 948 066 | −0,52 | 107,01 | −2 196 843 | 422 468 724 | |
| 2015-12-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −49 284 | 3 968 596 | −1,23 | 106,13 | −5 230 752 | 421 206 540 | |
| 2015-12-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −80 186 | 4 017 880 | −1,96 | 105,33 | −8 445 871 | 423 197 274 | |
| 2015-12-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 150 000 | 4 098 066 | 3,80 | 14,50 | 2 175 375 | 59 432 202 | |
| 2015-11-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock option (right to buy) |
M - Exercise | X | −150 000 | 150 000 | −50,00 | |||
| 2015-11-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −107 583 | 3 948 066 | −2,65 | 109,58 | −11 788 827 | 432 624 729 | |
| 2015-11-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −42 417 | 4 055 649 | −1,04 | 109,02 | −4 624 200 | 442 137 120 | |
| 2015-11-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 150 000 | 4 098 066 | 3,80 | 14,50 | 2 175 375 | 59 432 202 | |
| 2015-10-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock option (right to buy) |
M - Exercise | X | −150 000 | 300 000 | −33,33 | |||
| 2015-10-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −62 500 | 3 948 066 | −1,56 | 97,97 | −6 122 950 | 386 780 971 | |
| 2015-10-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −87 500 | 4 010 566 | −2,14 | 97,14 | −8 499 339 | 389 567 532 | |
| 2015-10-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 150 000 | 4 098 066 | 3,80 | 14,50 | 2 175 375 | 59 432 202 | |
| 2015-09-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock option (right to buy) |
M - Exercise | X | −150 000 | 450 000 | −25,00 | |||
| 2015-09-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −1 500 | 3 948 066 | −0,04 | 104,45 | −156 669 | 412 359 701 | |
| 2015-09-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −51 672 | 3 949 566 | −1,29 | 103,64 | −5 355 209 | 409 327 096 | |
| 2015-09-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −45 844 | 4 001 238 | −1,13 | 102,67 | −4 706 959 | 410 820 710 | |
| 2015-09-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −50 984 | 4 047 082 | −1,24 | 101,81 | −5 190 773 | 412 040 703 | |
| 2015-09-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 150 000 | 4 098 066 | 3,80 | 14,50 | 2 175 375 | 59 432 202 | |
| 2015-08-26 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −16 800 | 0 | −100,00 | 106,45 | −1 788 384 | ||
| 2015-08-26 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −56 613 | 16 800 | −77,12 | 105,68 | −5 982 805 | 1 775 407 | |
| 2015-08-26 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −59 800 | 73 413 | −44,89 | 104,33 | −6 238 683 | 7 658 870 | |
| 2015-08-26 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
A - Award | 133 213 | 133 213 | |||||
| 2015-08-26 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
G - Gift | −133 213 | 3 948 066 | −3,26 | ||||
| 2015-08-26 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
G - Gift | −133 213 | 4 081 279 | −3,16 | ||||
| 2015-08-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock option (right to buy) |
M - Exercise | X | −150 000 | 600 000 | −20,00 | |||
| 2015-08-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −65 508 | 4 214 492 | −1,53 | 119,52 | −7 829 523 | 503 716 505 | |
| 2015-08-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −84 492 | 4 280 000 | −1,94 | 118,91 | −10 047 096 | 508 942 504 | |
| 2015-08-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 150 000 | 4 364 492 | 3,56 | 14,50 | 2 175 375 | 63 296 045 | |
| 2015-07-06 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock option (right to buy) |
M - Exercise | X | −150 000 | 750 000 | −16,67 | |||
| 2015-07-06 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −16 625 | 4 214 492 | −0,39 | 118,01 | −1 961 918 | 497 352 622 | |
| 2015-07-06 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −41 115 | 4 231 117 | −0,96 | 117,06 | −4 813 111 | 495 314 019 | |
| 2015-07-06 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −92 260 | 4 272 232 | −2,11 | 115,92 | −10 694 632 | 495 230 298 | |
| 2015-07-06 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 150 000 | 4 364 492 | 3,56 | 14,50 | 2 175 375 | 63 296 045 | |
| 2015-06-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock option (right to buy) |
M - Exercise | X | −150 000 | 900 000 | −14,29 | |||
| 2015-06-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −103 200 | 4 255 876 | −2,37 | 114,25 | −11 790 714 | 486 238 514 | |
| 2015-06-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −46 800 | 4 359 076 | −1,06 | 113,28 | −5 301 630 | 493 807 899 | |
| 2015-06-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 150 000 | 4 405 876 | 3,52 | 14,50 | 2 175 375 | 63 896 217 | |
| 2015-05-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock option (right to buy) |
M - Exercise | X | −150 000 | 1 050 000 | −12,50 | |||
| 2015-05-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −35 200 | 4 255 876 | −0,82 | 105,97 | −3 730 214 | 451 003 691 | |
| 2015-05-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −66 159 | 4 291 076 | −1,52 | 105,21 | −6 960 330 | 451 447 371 | |
| 2015-05-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −34 241 | 4 357 235 | −0,78 | 104,05 | −3 562 841 | 453 378 580 | |
| 2015-05-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −14 400 | 4 391 476 | −0,33 | 103,41 | −1 489 105 | 454 122 972 | |
| 2015-05-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 150 000 | 4 405 876 | 3,52 | 14,50 | 2 175 375 | 63 896 217 | |
| 2015-04-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock option (right to buy) |
M - Exercise | X | −150 000 | 1 200 000 | −11,11 | |||
| 2015-04-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −4 044 | 4 255 876 | −0,09 | 97,88 | −395 826 | 416 563 866 | |
| 2015-04-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −66 979 | 4 259 920 | −1,55 | 97,19 | −6 509 970 | 414 039 516 | |
| 2015-04-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −78 977 | 4 326 899 | −1,79 | 96,30 | −7 605 667 | 416 690 326 | |
| 2015-04-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 150 000 | 4 405 876 | 3,52 | 14,50 | 2 175 375 | 63 896 217 | |
| 2015-03-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock option (right to buy) |
M - Exercise | X | −150 000 | 1 350 000 | −10,00 | |||
| 2015-03-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −150 000 | 4 255 876 | −3,40 | 103,51 | −15 526 245 | 440 518 490 | |
| 2015-03-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 150 000 | 4 405 876 | 3,52 | 14,50 | 2 175 375 | 63 896 217 | |
| 2015-02-19 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
F - Taxes | −244 205 | 4 255 876 | −5,43 | 103,84 | −25 358 247 | 441 930 164 | |
| 2015-02-19 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
A - Award | 312 000 | 4 500 081 | 7,45 | ||||
| 2015-02-19 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
A - Award | 64 846 | 4 188 081 | 1,57 | ||||
| 2015-02-19 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
A - Award | 248 | 4 123 235 | 0,01 | 85,61 | 21 232 | 352 998 395 | |
| 2015-02-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock option (right to buy) |
M - Exercise | X | −150 000 | 1 500 000 | −9,09 | |||
| 2015-02-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −4 067 | 4 122 987 | −0,10 | 106,81 | −434 388 | 440 367 995 | |
| 2015-02-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −44 733 | 4 127 054 | −1,07 | 105,99 | −4 741 219 | 437 423 565 | |
| 2015-02-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −101 200 | 4 171 787 | −2,37 | 105,13 | −10 639 642 | 438 599 992 | |
| 2015-02-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 150 000 | 4 272 987 | 3,64 | 14,50 | 2 175 375 | 61 968 994 | |
| 2015-02-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock option (right to buy) |
A - Award | 169 820 | 169 820 | |||||
| 2015-01-06 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −100 | 4 122 987 | 0,00 | 96,65 | −9 665 | 398 486 694 | |
| 2015-01-06 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock option (right to buy) |
M - Exercise | X | −150 000 | 1 650 000 | −8,33 | |||
| 2015-01-06 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −17 700 | 4 123 087 | −0,43 | 95,92 | −1 697 731 | 395 474 136 | |
| 2015-01-06 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −132 200 | 4 140 787 | −3,09 | 95,01 | −12 559 992 | 393 405 821 | |
| 2015-01-06 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 150 000 | 4 272 987 | 3,64 | 14,50 | 2 175 375 | 61 968 994 | |
| 2014-12-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock option (right to buy) |
M - Exercise | X | −140 633 | 0 | −100,00 | |||
| 2014-12-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −34 900 | 4 122 987 | −0,84 | 101,45 | −3 540 661 | 418 283 628 | |
| 2014-12-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −105 733 | 4 157 887 | −2,48 | 100,48 | −10 624 168 | 417 789 059 | |
| 2014-12-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 140 633 | 4 263 620 | 3,41 | 8,00 | 1 125 767 | 34 130 278 | |
| 2014-11-26 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
G - Gift | −306 400 | 4 122 987 | −6,92 | ||||
| 2014-11-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock option (right to buy) |
M - Exercise | X | −140 625 | 140 633 | −50,00 | |||
| 2014-11-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −9 025 | 4 429 387 | −0,20 | 112,42 | −1 014 617 | 497 964 532 | |
| 2014-11-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −20 400 | 4 438 412 | −0,46 | 111,83 | −2 281 405 | 496 363 592 | |
| 2014-11-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −55 454 | 4 458 812 | −1,23 | 110,17 | −6 109 190 | 491 213 050 | |
| 2014-11-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −55 746 | 4 514 266 | −1,22 | 109,78 | −6 119 891 | 495 583 796 | |
| 2014-11-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 140 625 | 4 570 012 | 3,17 | 8,00 | 1 125 703 | 36 582 946 | |
| 2014-10-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock option (right to buy) |
M - Exercise | X | −140 625 | 281 258 | −33,33 | |||
| 2014-10-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −1 400 | 4 429 387 | −0,03 | 107,41 | −150 374 | 475 760 458 | |
| 2014-10-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −29 725 | 4 430 787 | −0,67 | 106,60 | −3 168 795 | 472 338 288 | |
| 2014-10-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −109 500 | 4 460 512 | −2,40 | 105,70 | −11 574 676 | 471 497 529 | |
| 2014-10-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 140 625 | 4 570 012 | 3,17 | 8,00 | 1 125 703 | 36 582 946 | |
| 2014-09-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock option (right to buy) |
M - Exercise | X | −140 625 | 421 883 | −25,00 | |||
| 2014-09-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −68 000 | 4 429 387 | −1,51 | 109,01 | −7 412 605 | 482 842 605 | |
| 2014-09-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −72 625 | 4 497 387 | −1,59 | 108,30 | −7 865 309 | 487 068 361 | |
| 2014-09-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 140 625 | 4 570 012 | 3,17 | 8,00 | 1 125 703 | 36 582 946 | |
| 2014-08-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock option (right to buy) |
M - Exercise | X | −140 625 | 562 508 | −20,00 | |||
| 2014-08-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −41 500 | 4 429 387 | −0,93 | 92,10 | −3 822 017 | 407 932 369 | |
| 2014-08-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −99 125 | 4 470 887 | −2,17 | 91,30 | −9 049 795 | 408 177 676 | |
| 2014-08-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 140 625 | 4 570 012 | 3,17 | 8,00 | 1 125 703 | 36 582 946 | |
| 2014-07-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock option (right to buy) |
M - Exercise | X | −140 625 | 703 133 | −16,67 | |||
| 2014-07-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −18 100 | 4 429 387 | −0,41 | 85,40 | −1 545 678 | 378 254 590 | |
| 2014-07-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −92 300 | 4 447 487 | −2,03 | 85,01 | −7 846 728 | 378 095 547 | |
| 2014-07-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −30 225 | 4 539 787 | −0,66 | 83,96 | −2 537 555 | 381 140 087 | |
| 2014-07-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 140 625 | 4 570 012 | 3,17 | 8,00 | 1 125 703 | 36 582 946 | |
| 2014-06-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock option (right to buy) |
M - Exercise | X | −140 625 | 843 758 | −14,29 | |||
| 2014-06-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −140 625 | 4 429 387 | −3,08 | 81,32 | −11 435 836 | 360 204 395 | |
| 2014-06-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 140 625 | 4 570 012 | 3,17 | 8,00 | 1 125 703 | 36 582 946 | |
| 2014-05-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock option (right to buy) |
M - Exercise | X | −140 625 | 984 383 | −12,50 | |||
| 2014-05-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −74 064 | 4 429 387 | −1,64 | 79,36 | −5 877 564 | 351 506 851 | |
| 2014-05-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −66 561 | 4 503 451 | −1,46 | 78,64 | −5 234 470 | 354 159 043 | |
| 2014-05-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 140 625 | 4 570 012 | 3,17 | 8,00 | 1 125 703 | 36 582 946 | |
| 2014-04-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock option (right to buy) |
M - Exercise | X | −140 625 | 1 125 008 | −11,11 | |||
| 2014-04-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −68 910 | 4 429 387 | −1,53 | 73,47 | −5 062 652 | 325 416 432 | |
| 2014-04-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −71 715 | 4 498 297 | −1,57 | 73,06 | −5 239 376 | 328 637 932 | |
| 2014-04-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 140 625 | 4 570 012 | 3,17 | 8,00 | 1 125 703 | 36 582 946 | |
| 2014-03-10 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
F - Taxes | −187 848 | 4 429 387 | −4,07 | 79,92 | −15 012 812 | 353 996 609 | |
| 2014-03-10 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
A - Award | 360 000 | 4 617 235 | 8,46 | ||||
| 2014-03-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock option (right to buy) |
M - Exercise | X | −140 625 | 1 265 633 | −10,00 | |||
| 2014-03-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −40 958 | 4 257 235 | −0,95 | 82,36 | −3 373 452 | 350 641 626 | |
| 2014-03-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −99 667 | 4 298 193 | −2,27 | 81,49 | −8 121 874 | 350 260 177 | |
| 2014-03-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 140 625 | 4 397 860 | 3,30 | 8,00 | 1 125 703 | 35 204 869 | |
| 2014-03-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
A - Award | 968 | 4 257 235 | 0,02 | 21,94 | 21 243 | 93 424 596 | |
| 2014-02-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock option (right to buy) |
M - Exercise | X | −140 625 | 1 406 258 | −9,09 | |||
| 2014-02-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −500 | 4 256 267 | −0,01 | 81,83 | −40 915 | 348 290 329 | |
| 2014-02-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −32 725 | 4 256 767 | −0,76 | 81,17 | −2 656 223 | 345 513 264 | |
| 2014-02-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −49 000 | 4 289 492 | −1,13 | 80,21 | −3 930 226 | 344 054 577 | |
| 2014-02-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −58 400 | 4 338 492 | −1,33 | 79,05 | −4 616 724 | 342 972 977 | |
| 2014-02-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 140 625 | 4 396 892 | 3,30 | 8,00 | 1 125 703 | 35 197 120 | |
| 2014-02-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock option (right to buy) |
A - Award | 162 260 | 162 260 | |||||
| 2014-01-27 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
A - Award | 43 146 | 4 256 267 | 1,02 | ||||
| 2014-01-27 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
A - Award | 78 000 | 4 213 121 | 1,89 | ||||
| 2014-01-24 |
|
5 | GILD |
GILEAD SCIENCES INC
Common Stock |
A - Award | 78 000 | 4 135 121 | 1,92 | ||||
| 2014-01-06 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock option (right to buy) |
M - Exercise | X | −140 625 | 1 546 883 | −8,33 | |||
| 2014-01-06 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −140 625 | 4 057 121 | −3,35 | 75,02 | −10 550 180 | 304 379 417 | |
| 2014-01-06 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 140 625 | 4 197 746 | 3,47 | 8,00 | 1 125 703 | 33 602 957 | |
| 2013-12-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock option (right to buy) |
M - Exercise | X | −282 242 | 0 | −100,00 | |||
| 2013-12-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −17 742 | 4 057 121 | −0,44 | 74,79 | −1 326 862 | 303 417 880 | |
| 2013-12-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −264 500 | 4 074 863 | −6,10 | 74,23 | −19 633 835 | 302 477 080 | |
| 2013-12-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 282 242 | 4 339 363 | 6,96 | 7,63 | 2 154 212 | 33 120 188 | |
| 2013-11-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock option (right to buy) |
M - Exercise | X | −282 242 | 282 242 | −50,00 | |||
| 2013-11-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −282 242 | 4 057 121 | −6,50 | 70,83 | −19 990 213 | 287 351 681 | |
| 2013-11-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 282 242 | 4 339 363 | 6,96 | 7,63 | 2 154 212 | 33 120 188 | |
| 2013-10-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock option (right to buy) |
M - Exercise | X | −282 242 | 564 484 | −33,33 | |||
| 2013-10-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −282 242 | 4 057 121 | −6,50 | 62,70 | −17 696 545 | 254 381 081 | |
| 2013-10-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 282 242 | 4 339 363 | 6,96 | 7,63 | 2 154 212 | 33 120 188 | |
| 2013-09-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock option (right to buy) |
M - Exercise | X | −282 242 | 846 726 | −25,00 | |||
| 2013-09-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −14 500 | 4 057 121 | −0,36 | 61,45 | −890 990 | 249 300 348 | |
| 2013-09-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −267 742 | 4 071 621 | −6,17 | 60,95 | −16 318 500 | 248 159 600 | |
| 2013-09-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 282 242 | 4 339 363 | 6,96 | 7,63 | 2 154 212 | 33 120 188 | |
| 2013-08-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock option (right to buy) |
M - Exercise | X | −282 242 | 1 128 968 | −20,00 | |||
| 2013-08-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −36 242 | 4 057 121 | −0,89 | 62,04 | −2 248 341 | 251 691 210 | |
| 2013-08-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −246 000 | 4 093 363 | −5,67 | 61,55 | −15 141 398 | 251 948 130 | |
| 2013-08-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 282 242 | 4 339 363 | 6,96 | 7,63 | 2 154 212 | 33 120 188 | |
| 2013-07-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock option (right to buy) |
M - Exercise | X | −282 242 | 1 411 210 | −16,67 | |||
| 2013-07-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −20 800 | 4 057 121 | −0,51 | 52,64 | −1 094 837 | 213 552 244 | |
| 2013-07-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −261 442 | 4 077 921 | −6,02 | 51,95 | −13 582 984 | 211 864 715 | |
| 2013-07-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 282 242 | 4 339 363 | 6,96 | 7,63 | 2 154 212 | 33 120 188 | |
| 2013-06-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock option (right to buy) |
M - Exercise | X | −282 242 | 1 693 452 | −14,29 | |||
| 2013-06-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −3 542 | 4 057 121 | −0,09 | 54,59 | −193 352 | 221 471 744 | |
| 2013-06-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −24 800 | 4 060 663 | −0,61 | 53,99 | −1 339 002 | 219 243 317 | |
| 2013-06-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −225 700 | 4 085 463 | −5,24 | 52,80 | −11 916 599 | 215 705 910 | |
| 2013-06-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −28 200 | 4 311 163 | −0,65 | 51,91 | −1 463 918 | 223 801 094 | |
| 2013-06-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 282 242 | 4 339 363 | 6,96 | 7,63 | 2 154 212 | 33 120 188 | |
| 2013-05-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock option (right to buy) |
M - Exercise | X | −282 242 | 1 975 694 | −12,50 | |||
| 2013-05-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −282 242 | 4 057 121 | −6,50 | 50,17 | −14 160 956 | 203 558 338 | |
| 2013-05-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 282 242 | 4 339 363 | 6,96 | 7,63 | 2 154 212 | 33 120 188 | |
| 2013-04-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock option (right to buy) |
M - Exercise | X | −282 242 | 2 257 936 | −11,11 | |||
| 2013-04-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −181 242 | 4 057 121 | −4,28 | 48,47 | −8 784 564 | 196 643 381 | |
| 2013-04-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −101 000 | 4 238 363 | −2,33 | 48,01 | −4 848 970 | 203 482 112 | |
| 2013-04-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 282 242 | 4 339 363 | 6,96 | 7,63 | 2 154 212 | 33 120 188 | |
| 2013-03-08 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
F - Taxes | −55 311 | 4 057 121 | −1,34 | 45,40 | −2 511 119 | 184 193 293 | |
| 2013-03-08 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
A - Award | 106 000 | 4 112 432 | 2,65 | ||||
| 2013-03-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock option (right to buy) |
M - Exercise | X | −282 242 | 2 540 178 | −10,00 | |||
| 2013-03-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −67 535 | 4 006 432 | −1,66 | 43,43 | −2 932 755 | 173 982 114 | |
| 2013-03-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −214 707 | 4 073 967 | −5,01 | 43,05 | −9 243 308 | 175 387 539 | |
| 2013-03-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 282 242 | 4 288 674 | 7,04 | 7,63 | 2 154 212 | 32 733 304 | |
| 2013-02-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock option (right to buy) |
A - Award | 392 750 | 392 750 | |||||
| 2013-02-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock option (right to buy) |
M - Exercise | X | −282 242 | 2 822 420 | −9,09 | |||
| 2013-02-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −11 000 | 4 005 464 | −0,27 | 41,00 | −451 053 | 164 243 250 | |
| 2013-02-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −271 242 | 4 016 464 | −6,33 | 40,40 | −10 959 425 | 162 283 621 | |
| 2013-02-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 282 242 | 4 287 706 | 7,05 | 7,63 | 2 154 212 | 32 725 916 | |
| 2013-01-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Incentive Stock option (right to buy) |
M - Exercise | X | −141 121 | 1 552 331 | −8,33 | |||
| 2013-01-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −52 810 | 2 002 732 | −2,57 | 74,67 | −3 943 212 | 149 539 793 | |
| 2013-01-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −88 311 | 2 055 542 | −4,12 | 74,34 | −6 565 261 | 152 814 131 | |
| 2013-01-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 141 121 | 2 143 853 | 7,05 | 15,26 | 2 154 212 | 32 725 916 | |
| 2012-12-12 |
|
4 | GILD |
GILEAD SCIENCES INC
Incentive Stock option (right to buy) |
M - Exercise | −6 246 | 0 | −100,00 | ||||
| 2012-12-12 |
|
4 | GILD |
GILEAD SCIENCES INC
Incentive Stock option (right to buy) |
M - Exercise | −6 548 | 0 | −100,00 | ||||
| 2012-12-12 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 6 246 | 2 002 732 | 0,31 | 16,01 | 99 998 | 32 063 739 | |
| 2012-12-12 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 6 548 | 1 996 486 | 0,33 | 15,26 | 99 955 | 30 476 359 | |
| 2012-12-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock option (right to buy) |
M - Exercise | X | −134 320 | 0 | −100,00 | |||
| 2012-12-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Incentive Stock option (right to buy) |
M - Exercise | X | −11 180 | 0 | −100,00 | |||
| 2012-12-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −67 242 | 1 989 938 | −3,27 | 75,33 | −5 065 246 | 149 899 244 | |
| 2012-12-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −78 258 | 2 057 180 | −3,66 | 74,74 | −5 849 347 | 153 762 685 | |
| 2012-12-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 11 180 | 2 135 438 | 0,53 | 8,94 | 99 977 | 19 096 154 | |
| 2012-12-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 134 320 | 2 124 258 | 6,75 | 8,94 | 1 201 157 | 18 996 177 | |
| 2012-11-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock option (right to buy) |
M - Exercise | X | −145 450 | 134 320 | −51,99 | |||
| 2012-11-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −15 100 | 1 989 938 | −0,75 | 68,18 | −1 029 569 | 135 680 739 | |
| 2012-11-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −130 350 | 2 005 038 | −6,10 | 67,65 | −8 818 021 | 135 638 415 | |
| 2012-11-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 145 450 | 2 135 388 | 7,31 | 8,94 | 1 300 687 | 19 095 707 | |
| 2012-10-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock option (right to buy) |
M - Exercise | X | −145 450 | 279 770 | −34,21 | |||
| 2012-10-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −14 000 | 1 989 938 | −0,70 | 68,09 | −953 240 | 135 492 093 | |
| 2012-10-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −131 450 | 2 003 938 | −6,16 | 67,47 | −8 869 392 | 135 212 711 | |
| 2012-10-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 145 450 | 2 135 388 | 7,31 | 8,94 | 1 300 687 | 19 095 707 | |
| 2012-09-06 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock option (right to buy) |
M - Exercise | X | −145 450 | 425 220 | −25,49 | |||
| 2012-09-06 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −32 304 | 1 989 938 | −1,60 | 58,13 | −1 877 861 | 115 676 887 | |
| 2012-09-06 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −113 146 | 2 022 242 | −5,30 | 57,56 | −6 512 152 | 116 390 745 | |
| 2012-09-06 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 145 450 | 2 135 388 | 7,31 | 8,94 | 1 300 687 | 19 095 707 | |
| 2012-08-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock option (right to buy) |
M - Exercise | X | −145 450 | 570 670 | −20,31 | |||
| 2012-08-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −56 313 | 1 989 938 | −2,75 | 54,25 | −3 054 963 | 107 953 540 | |
| 2012-08-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −89 137 | 2 046 251 | −4,17 | 53,84 | −4 799 127 | 110 169 949 | |
| 2012-08-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 145 450 | 2 135 388 | 7,31 | 8,94 | 1 300 687 | 19 095 707 | |
| 2012-08-02 |
|
4 | GPRO |
GEN PROBE INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −7 500 | 0 | −100,00 | ||||
| 2012-08-02 |
|
4 | GPRO |
GEN PROBE INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −7 500 | 0 | −100,00 | 37,10 | −278 250 | ||
| 2012-08-02 |
|
4 | GPRO |
GEN PROBE INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −7 500 | 0 | −100,00 | 39,51 | −296 325 | ||
| 2012-08-02 |
|
4 | GPRO |
GEN PROBE INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −7 500 | 0 | −100,00 | 25,00 | −187 500 | ||
| 2012-08-02 |
|
4 | GPRO |
GEN PROBE INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −20 000 | 0 | −100,00 | 15,31 | −306 200 | ||
| 2012-08-02 |
|
4 | GPRO |
GEN PROBE INC
Common Stock |
D - Sale to Issuer | −5 844 | 0 | −100,00 | 82,75 | −483 591 | ||
| 2012-07-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock option (right to buy) |
M - Exercise | X | −145 450 | 716 120 | −16,88 | |||
| 2012-07-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −145 450 | 1 989 938 | −6,81 | 51,32 | −7 464 683 | 102 126 205 | |
| 2012-07-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 145 450 | 2 135 388 | 7,31 | 8,94 | 1 300 687 | 19 095 707 | |
| 2012-07-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
A - Award | 733 | 1 989 938 | 0,04 | 29,02 | 21 271 | 57 746 011 | |
| 2012-06-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock option (right to buy) |
M - Exercise | X | −145 450 | 861 570 | −14,44 | |||
| 2012-06-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −38 850 | 1 989 205 | −1,92 | 49,04 | −1 905 192 | 97 550 016 | |
| 2012-06-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −106 600 | 2 028 055 | −4,99 | 48,65 | −5 186 218 | 98 667 309 | |
| 2012-06-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 145 450 | 2 134 655 | 7,31 | 8,94 | 1 300 687 | 19 089 152 | |
| 2012-05-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock option (right to buy) |
M - Exercise | X | −145 450 | 1 007 020 | −12,62 | |||
| 2012-05-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −145 450 | 1 989 205 | −6,81 | 51,71 | −7 521 496 | 102 865 570 | |
| 2012-05-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 145 450 | 2 134 655 | 7,31 | 8,94 | 1 300 687 | 19 089 152 | |
| 2012-04-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock option (right to buy) |
M - Exercise | X | −145 450 | 1 152 470 | −11,21 | |||
| 2012-04-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −145 450 | 1 989 205 | −6,81 | 48,38 | −7 036 842 | 96 237 340 | |
| 2012-04-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 145 450 | 2 134 655 | 7,31 | 8,94 | 1 300 687 | 19 089 152 | |
| 2012-04-04 |
|
4 | GPRO |
GEN PROBE INC
Common Stock |
A - Award | 250 | 5 844 | 4,47 | 67,26 | 16 815 | 393 067 | |
| 2012-03-14 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
F - Taxes | −35 010 | 1 989 205 | −1,73 | 46,16 | −1 616 062 | 91 821 703 | |
| 2012-03-14 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
A - Award | 75 000 | 2 024 215 | 3,85 | ||||
| 2012-03-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock option (right to buy) |
M - Exercise | X | −145 450 | 1 297 920 | −10,08 | |||
| 2012-03-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −145 450 | 1 949 215 | −6,94 | 46,23 | −6 723 804 | 90 107 531 | |
| 2012-03-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 145 450 | 2 094 665 | 7,46 | 8,94 | 1 300 687 | 18 731 542 | |
| 2012-02-09 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock option (right to buy) |
M - Exercise | X | −145 450 | 0 | −100,00 | |||
| 2012-02-09 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −90 150 | 1 949 215 | −4,42 | 55,20 | −4 976 641 | 107 604 465 | |
| 2012-02-09 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −55 300 | 2 039 365 | −2,64 | 54,92 | −3 036 888 | 111 994 992 | |
| 2012-02-09 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 145 450 | 2 094 665 | 7,46 | 8,94 | 1 300 687 | 18 731 542 | |
| 2012-01-30 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock option (right to buy) |
A - Award | 331 000 | 331 000 | |||||
| 2012-01-05 |
|
4 | GPRO |
GEN PROBE INC
Common Stock |
A - Award | 354 | 5 594 | 6,76 | 58,93 | 20 861 | 329 654 | |
| 2011-09-06 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock option (right to buy) |
M - Exercise | −92 320 | 276 960 | −25,00 | ||||
| 2011-09-06 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −92 320 | 1 949 215 | −4,52 | 40,07 | −3 699 013 | 78 099 782 | |
| 2011-09-06 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 92 320 | 2 041 535 | 4,74 | 8,22 | 758 760 | 16 778 968 | |
| 2008-08-14 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −70 000 | 803 376 | −8,01 | ||||
| 2008-08-14 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −70 000 | 1 550 229 | −4,32 | 56,82 | −3 977 729 | 88 091 298 | |
| 2008-08-14 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 70 000 | 1 620 229 | 4,52 | 3,65 | 255 395 | 5 911 406 | |
| 2006-01-27 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (right to buy) |
A - Award | 450 000 | 450 000 | |||||
| 2005-01-28 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock Option (right to buy) |
A - Award | 421 877 | 421 877 | |||||
| 2005-01-28 |
|
4 | GILD |
GILEAD SCIENCES INC
Incentive Stock Option (right to buy) |
A - Award | 3 123 | 3 123 |